HempStreet Launches Palliative Care Platform ‘Dignity' in Ayurvedic Cannabis Sector

HempStreet, with the launch of 'Dignity,' aims to enhance accessibility to palliative care services while reducing the daily cost of care.

HempStreet, a research-to-retail venture based in New Delhi within the ayurvedic cannabis sector, has introduced a palliative care platform, Dignity.

The newly launched platform is designed to help patients facing terminal illnesses such as cancer, leukemia, Parkinson's disease, epilepsy, and others.

Sharing thoughts, Abhishek Mohan, founder & CEO, HempStreet, said, “We feel the actual definition of palliative care should be expanded to include every person above 60 years of age who experiences a single or multiple chronic illnesses. This would translate to about 20 to 25 million individuals at the minimum in India."

The palliative care platform seeks to bring a dignified upgrade to the landscape of end-of-life care in India, ensuring that everyone receives the compassionate support they deserve.

What are Dignity's Offerings

With the launch of 'Dignity,' HempStreet aims to achieve two primary objectives: significantly enhance accessibility to palliative care services by up to 2 to 3 times while simultaneously reducing the daily cost of care.

This platform seeks to improve patient outcomes by offering comprehensive healthcare solutions, including access to doctors, counselors, emotional support services, emergency assistance, and safe medication management, all at a lower cost.

HempStreet's dispensation network spans thousands of clinics across 26 states in India. The introduction of 'Dignity' by HempStreet aims to be a step forward in India's palliative care landscape, promising enhanced accessibility, affordability, and comprehensive support for patients facing terminal illnesses.

Growing Concern of Palliative Care in India

In India, palliative care services often face challenges due to barriers such as population density, poverty, and stringent policies, leaving less than 1% of the population able to access healthcare centers.

Particularly for terminally ill senior citizens, these challenges exacerbate, leading to a deterioration in their quality of life.

HempStreet's initiative seeks to address the urgent need for enhanced palliative care services in India.

Kerala, known for having more palliative care centers than the rest of the country, serves as the initial implementation site for 'Dignity.' The platform aims to amplify the reach of palliative care personnel and reduce the cost of care and medication delivery.

CEO Mohan underlines HempStreet's dedication to driving positive healthcare delivery changes nationwide, inviting all stakeholders to join the endeavor to redefine the standards of palliative care in India.

He adds that 'Dignity' is not limited to HempStreet's products; it aims to unite various stakeholders involved in palliative care, ensuring comprehensive support tailored to individual needs.

Per the startup, the distinctive feature of 'Dignity' lies in its ability to bring together various stakeholders in palliative care, amplifying the reach of palliative care professionals, ensuring safe access to medication, and providing comprehensive support tailored to individual needs.

Claiming to be India's first research-to-retail ayurvedic medicinal cannabis venture, HempStreet aims to merge the ancient science of Ayurveda with modern cannabis research.

The startup focuses on developing sustainable and economical solutions for mass ailments while ensuring end-to-end blockchain technology-based supply chain tracking to minimize abuse.

Recently, HempStreet partnered with MGC Pharma (EU), Gynica (Israel), and Amrita School of Ayurveda, aiming to expand its knowledge base, access cutting-edge research, and

advancing the availability of safe and effective cannabis-based medicines, with a focus on clinical validation.

In a similar development addressing chronic illnesses, Metropolis Healthcare Limited introduced the Next Best Action (NBA) initiative, a patient education program to tackle the rising prevalence of chronic diseases.

The NBA initiative aims to empower patients to take charge of their health and prevent severe complications associated with chronic conditions. By leveraging the results of basic blood parameters, NBA recommends follow-up tests based on the latest research and guidelines tailored to each patient, providing a comprehensive assessment of various body systems.